PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen today announced that it has successfully concluded multiple
registration procedures for Lenalidomide capsules. Alvogen received
[...]
PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen today announced that it has successfully concluded multiple
registration procedures for Lenalidomide capsules. Alvogen received
[...]
PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen today announced the successful closure of the decentralized
procedure for RemurelTM (glatiramer acetate) 40 mg/mL, the
[...]